Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position.
Winter E, Gozzi GJ, Chiaradia-Delatorre LD, Daflon-Yunes N, Terreux R, Gauthier C, Mascarello A, Leal PC, Cadena SM, Yunes RA, Nunes RJ, Creczynski-Pasa TB, Di Pietro A.
Winter E, et al. Among authors: nunes rj.
Drug Des Devel Ther. 2014 May 27;8:609-19. doi: 10.2147/DDDT.S56625. eCollection 2014.
Drug Des Devel Ther. 2014.
PMID: 24920885
Free PMC article.